Report Detail

Request for Sample of this report

Other Global Diagnostic Exosome Biomarker Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4513005
    • |
  • 18 February, 2023
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

The fusion of plasma membrane with the internal vesicle fusion leads to the secretion of nanovescicles called exosomes into the extracellular environment. The exosomes are released in easily accessible body fluids such as urine and blood and hence acts as a precious source of biomedical tool. As cancer is a booming research area, exosomes may act as a very useful biomarkers for the diagnosis and prognosis of malignant tumor. The application of exosome as a potential biomarker for the various neurodegenerative disorders is also under investigation.
According to our (Global Info Research) latest study, the global Diagnostic Exosome Biomarker market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Diagnostic Exosome Biomarker market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Diagnostic Exosome Biomarker market size and forecasts, in consumption value ($ Million), 2018-2029
Global Diagnostic Exosome Biomarker market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Diagnostic Exosome Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Diagnostic Exosome Biomarker market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diagnostic Exosome Biomarker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diagnostic Exosome Biomarker market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 101Bio, AMS Biotechnology, BioRegenerative Sciences, Cell Guidance Systems and Codiak BioSciences, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Diagnostic Exosome Biomarker market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Membrane-bound Proteins
Soluble Proteins
Noncoding RNA
Others
Market segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by players, this report covers
101Bio
AMS Biotechnology
BioRegenerative Sciences
Cell Guidance Systems
Codiak BioSciences
Evomic Science
ExoCyte Therapeutics
Bio-Techne
Exovita biosciences
Immune Therapy Holdings
Lonza
Norgen Biotek
ReNeuron Group
Therapeutic Solutions International
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Diagnostic Exosome Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Diagnostic Exosome Biomarker, with revenue, gross margin and global market share of Diagnostic Exosome Biomarker from 2018 to 2023.
Chapter 3, the Diagnostic Exosome Biomarker competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Diagnostic Exosome Biomarker market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Diagnostic Exosome Biomarker.
Chapter 13, to describe Diagnostic Exosome Biomarker research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Diagnostic Exosome Biomarker
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Diagnostic Exosome Biomarker by Type
    • 1.3.1 Overview: Global Diagnostic Exosome Biomarker Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Diagnostic Exosome Biomarker Consumption Value Market Share by Type in 2022
    • 1.3.3 Membrane-bound Proteins
    • 1.3.4 Soluble Proteins
    • 1.3.5 Noncoding RNA
    • 1.3.6 Others
  • 1.4 Global Diagnostic Exosome Biomarker Market by Application
    • 1.4.1 Overview: Global Diagnostic Exosome Biomarker Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Ambulatory Surgical Centers
  • 1.5 Global Diagnostic Exosome Biomarker Market Size & Forecast
  • 1.6 Global Diagnostic Exosome Biomarker Market Size and Forecast by Region
    • 1.6.1 Global Diagnostic Exosome Biomarker Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Diagnostic Exosome Biomarker Market Size by Region, (2018-2029)
    • 1.6.3 North America Diagnostic Exosome Biomarker Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Diagnostic Exosome Biomarker Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Diagnostic Exosome Biomarker Market Size and Prospect (2018-2029)
    • 1.6.6 South America Diagnostic Exosome Biomarker Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Diagnostic Exosome Biomarker Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 101Bio
    • 2.1.1 101Bio Details
    • 2.1.2 101Bio Major Business
    • 2.1.3 101Bio Diagnostic Exosome Biomarker Product and Solutions
    • 2.1.4 101Bio Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 101Bio Recent Developments and Future Plans
  • 2.2 AMS Biotechnology
    • 2.2.1 AMS Biotechnology Details
    • 2.2.2 AMS Biotechnology Major Business
    • 2.2.3 AMS Biotechnology Diagnostic Exosome Biomarker Product and Solutions
    • 2.2.4 AMS Biotechnology Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 AMS Biotechnology Recent Developments and Future Plans
  • 2.3 BioRegenerative Sciences
    • 2.3.1 BioRegenerative Sciences Details
    • 2.3.2 BioRegenerative Sciences Major Business
    • 2.3.3 BioRegenerative Sciences Diagnostic Exosome Biomarker Product and Solutions
    • 2.3.4 BioRegenerative Sciences Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 BioRegenerative Sciences Recent Developments and Future Plans
  • 2.4 Cell Guidance Systems
    • 2.4.1 Cell Guidance Systems Details
    • 2.4.2 Cell Guidance Systems Major Business
    • 2.4.3 Cell Guidance Systems Diagnostic Exosome Biomarker Product and Solutions
    • 2.4.4 Cell Guidance Systems Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Cell Guidance Systems Recent Developments and Future Plans
  • 2.5 Codiak BioSciences
    • 2.5.1 Codiak BioSciences Details
    • 2.5.2 Codiak BioSciences Major Business
    • 2.5.3 Codiak BioSciences Diagnostic Exosome Biomarker Product and Solutions
    • 2.5.4 Codiak BioSciences Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Codiak BioSciences Recent Developments and Future Plans
  • 2.6 Evomic Science
    • 2.6.1 Evomic Science Details
    • 2.6.2 Evomic Science Major Business
    • 2.6.3 Evomic Science Diagnostic Exosome Biomarker Product and Solutions
    • 2.6.4 Evomic Science Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Evomic Science Recent Developments and Future Plans
  • 2.7 ExoCyte Therapeutics
    • 2.7.1 ExoCyte Therapeutics Details
    • 2.7.2 ExoCyte Therapeutics Major Business
    • 2.7.3 ExoCyte Therapeutics Diagnostic Exosome Biomarker Product and Solutions
    • 2.7.4 ExoCyte Therapeutics Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 ExoCyte Therapeutics Recent Developments and Future Plans
  • 2.8 Bio-Techne
    • 2.8.1 Bio-Techne Details
    • 2.8.2 Bio-Techne Major Business
    • 2.8.3 Bio-Techne Diagnostic Exosome Biomarker Product and Solutions
    • 2.8.4 Bio-Techne Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Bio-Techne Recent Developments and Future Plans
  • 2.9 Exovita biosciences
    • 2.9.1 Exovita biosciences Details
    • 2.9.2 Exovita biosciences Major Business
    • 2.9.3 Exovita biosciences Diagnostic Exosome Biomarker Product and Solutions
    • 2.9.4 Exovita biosciences Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Exovita biosciences Recent Developments and Future Plans
  • 2.10 Immune Therapy Holdings
    • 2.10.1 Immune Therapy Holdings Details
    • 2.10.2 Immune Therapy Holdings Major Business
    • 2.10.3 Immune Therapy Holdings Diagnostic Exosome Biomarker Product and Solutions
    • 2.10.4 Immune Therapy Holdings Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Immune Therapy Holdings Recent Developments and Future Plans
  • 2.11 Lonza
    • 2.11.1 Lonza Details
    • 2.11.2 Lonza Major Business
    • 2.11.3 Lonza Diagnostic Exosome Biomarker Product and Solutions
    • 2.11.4 Lonza Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Lonza Recent Developments and Future Plans
  • 2.12 Norgen Biotek
    • 2.12.1 Norgen Biotek Details
    • 2.12.2 Norgen Biotek Major Business
    • 2.12.3 Norgen Biotek Diagnostic Exosome Biomarker Product and Solutions
    • 2.12.4 Norgen Biotek Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Norgen Biotek Recent Developments and Future Plans
  • 2.13 ReNeuron Group
    • 2.13.1 ReNeuron Group Details
    • 2.13.2 ReNeuron Group Major Business
    • 2.13.3 ReNeuron Group Diagnostic Exosome Biomarker Product and Solutions
    • 2.13.4 ReNeuron Group Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 ReNeuron Group Recent Developments and Future Plans
  • 2.14 Therapeutic Solutions International
    • 2.14.1 Therapeutic Solutions International Details
    • 2.14.2 Therapeutic Solutions International Major Business
    • 2.14.3 Therapeutic Solutions International Diagnostic Exosome Biomarker Product and Solutions
    • 2.14.4 Therapeutic Solutions International Diagnostic Exosome Biomarker Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Therapeutic Solutions International Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Diagnostic Exosome Biomarker Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Diagnostic Exosome Biomarker by Company Revenue
    • 3.2.2 Top 3 Diagnostic Exosome Biomarker Players Market Share in 2022
    • 3.2.3 Top 6 Diagnostic Exosome Biomarker Players Market Share in 2022
  • 3.3 Diagnostic Exosome Biomarker Market: Overall Company Footprint Analysis
    • 3.3.1 Diagnostic Exosome Biomarker Market: Region Footprint
    • 3.3.2 Diagnostic Exosome Biomarker Market: Company Product Type Footprint
    • 3.3.3 Diagnostic Exosome Biomarker Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Diagnostic Exosome Biomarker Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Diagnostic Exosome Biomarker Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Diagnostic Exosome Biomarker Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Diagnostic Exosome Biomarker Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Diagnostic Exosome Biomarker Consumption Value by Type (2018-2029)
  • 6.2 North America Diagnostic Exosome Biomarker Consumption Value by Application (2018-2029)
  • 6.3 North America Diagnostic Exosome Biomarker Market Size by Country
    • 6.3.1 North America Diagnostic Exosome Biomarker Consumption Value by Country (2018-2029)
    • 6.3.2 United States Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Diagnostic Exosome Biomarker Consumption Value by Type (2018-2029)
  • 7.2 Europe Diagnostic Exosome Biomarker Consumption Value by Application (2018-2029)
  • 7.3 Europe Diagnostic Exosome Biomarker Market Size by Country
    • 7.3.1 Europe Diagnostic Exosome Biomarker Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 7.3.3 France Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Diagnostic Exosome Biomarker Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Diagnostic Exosome Biomarker Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Diagnostic Exosome Biomarker Market Size by Region
    • 8.3.1 Asia-Pacific Diagnostic Exosome Biomarker Consumption Value by Region (2018-2029)
    • 8.3.2 China Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 8.3.5 India Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Diagnostic Exosome Biomarker Consumption Value by Type (2018-2029)
  • 9.2 South America Diagnostic Exosome Biomarker Consumption Value by Application (2018-2029)
  • 9.3 South America Diagnostic Exosome Biomarker Market Size by Country
    • 9.3.1 South America Diagnostic Exosome Biomarker Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Diagnostic Exosome Biomarker Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Diagnostic Exosome Biomarker Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Diagnostic Exosome Biomarker Market Size by Country
    • 10.3.1 Middle East & Africa Diagnostic Exosome Biomarker Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Diagnostic Exosome Biomarker Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Diagnostic Exosome Biomarker Market Drivers
  • 11.2 Diagnostic Exosome Biomarker Market Restraints
  • 11.3 Diagnostic Exosome Biomarker Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Diagnostic Exosome Biomarker Industry Chain
  • 12.2 Diagnostic Exosome Biomarker Upstream Analysis
  • 12.3 Diagnostic Exosome Biomarker Midstream Analysis
  • 12.4 Diagnostic Exosome Biomarker Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Diagnostic Exosome Biomarker. Industry analysis & Market Report on Diagnostic Exosome Biomarker is a syndicated market report, published as Global Diagnostic Exosome Biomarker Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Diagnostic Exosome Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,246.84
    		4,870.26
    		6,493.68
    		543,784.80
    		815,677.20
    		1,087,569.60
    		290,475.60
    		435,713.40
    		580,951.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo